Achieve Life Sciences, Inc. Stock Split Ratio
Achieve Life Sciences, Inc. (ACHV) had Stock Split Ratio of 5.00% as of 2020-07-31, per its 10-K filed 2023-03-16.
Discontinued › Notes › Equity
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2023-03-16
- 2020-07-31: Stockholders' Equity Note, Stock Split, Conversion Ratio 5.00%.
- 2018-05-23: Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month 10.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month |
|---|---|---|
| 2020-07-31 | 5.00% 10-K · filed 2023-03-16 | |
| 2018-05-23 | 10.00% 10-K · filed 2021-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |